Sun Denied Over US Antitrust Challenge
Indian Firm May Not Appeal Ruling Rejecting Dismissal Bid
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
